Skip to Content

Humira

In the US, Humira (adalimumab systemic) is a member of the following drug classes: antirheumatics, TNF alfa inhibitors and is used to treat Ankylosing Spondylitis, Crohn's Disease, Crohn's Disease - Acute, Crohn's Disease - Maintenance, Hidradenitis Suppurativa, Juvenile Idiopathic Arthritis, Plaque Psoriasis, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Spondyloarthritis and Ulcerative Colitis.

US matches:

UK matches:

Ingredient matches for Humira

Adalimumab

Adalimumab is reported as an ingredient of Humira in the following countries:

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Bosnia & Herzegowina
  • Canada
  • Chile
  • China
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Ecuador
  • Egypt
  • France
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Ireland
  • Israel
  • Italy
  • Japan
  • Latvia
  • Lebanon
  • Lithuania
  • Mexico
  • Netherlands
  • New Zealand
  • Norway
  • Oman
  • Peru
  • Poland
  • Romania
  • Russian Federation
  • Serbia
  • Singapore
  • Slovakia
  • South Africa
  • South Korea
  • Sweden
  • Switzerland
  • Taiwan
  • Tunisia
  • Turkey
  • United Kingdom
  • United States
  • Venezuela

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide